← Back to Search

Positron Emission Tomography/Computed Tomography for Prostate Cancer

Phase 2
Waitlist Available
Led By Orhan K Oz, MD, PhD
Research Sponsored by Dana Mathews
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights

Study Summary

This trial will test if a new imaging method can better detect prostate cancer recurrence than current methods, and if so, if it can help guide treatment decisions.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Location of recurrence
Residual prostate cancer

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients with suspected BCR or metastatic prostate cancerExperimental Treatment2 Interventions
Patients with suspected BCR or metastatic prostate cancer
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Positron Emission Tomography/Computed Tomography
2020
Completed Phase 2
~20
68Ga PSMA-11 injection
2020
Completed Phase 2
~20

Find a Location

Who is running the clinical trial?

Dana MathewsLead Sponsor
2 Previous Clinical Trials
20 Total Patients Enrolled
2 Trials studying Prostate Cancer
20 Patients Enrolled for Prostate Cancer
Orhan K Oz, MD, PhDPrincipal InvestigatorUT Southwestern Medical Center
2 Previous Clinical Trials
20 Total Patients Enrolled
2 Trials studying Prostate Cancer
20 Patients Enrolled for Prostate Cancer
Neil Rofsky, MD, MHAPrincipal InvestigatorUT Southwestern Medical Center
2 Previous Clinical Trials
20 Total Patients Enrolled
2 Trials studying Prostate Cancer
20 Patients Enrolled for Prostate Cancer
~0 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top